Ratings by H.C. Wainwright (Douglas Tsao)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/7/2026 | Crinetics | CRNX | Downgrade | Neutral (Buy) |
42.03 (83.58) |
98.86% | Details | |
| 7/7/2026 | Theravance Biopharma | TBPH | Downgrade | Neutral (Buy) |
17.00 (16.93) |
-0.41% | Details | |
| 7/1/2026 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (Buy) |
|
Details | ||
| 6/29/2026 | Viridian Therapeutic | VRDN | Maintain | Buy (Buy) |
|
Details | ||
| 6/25/2026 | argenx SE | ARGX | Maintain | Buy (Buy) |
|
Details | ||
| 6/18/2026 | Alkermes | ALKS | Maintain | Neutral (Neutral) |
|
Details | ||
| 6/16/2026 | Neumora Therapeutics | NMRA | Maintain | Buy (N/A) |
|
Details | ||
| 6/15/2026 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 6/15/2026 | Crinetics | CRNX | Maintain | Buy (Buy) |
|
Details | ||
| 6/4/2026 | argenx SE | ARGX | Maintain | Buy (Buy) |
|
Details | ||
| 6/2/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/26/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (Buy) |
|
Details | ||
| 5/21/2026 | Roivant Sciences | ROIV | Maintain | Buy (Buy) |
|
Details | ||
| 5/21/2026 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2026 | Rezolute | RZLT | Maintain | Buy (Buy) |
|
Details | ||
| 5/12/2026 | Biohaven Pharma | BHVN | Maintain | Neutral (Neutral) |
|
Details | ||
| 5/4/2026 | Rezolute | RZLT | Maintain | Buy (Buy) |
|
Details | ||
| 4/29/2026 | Cabaletta Bio Inc. | CABA | Maintain | Buy (Buy) |
|
Details | ||
| 4/7/2026 | Viridian Therapeutic | VRDN | Maintain | Buy (Buy) |
|
Details | ||
| 4/7/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (Buy) |
|
Details | ||
| 4/1/2026 | Cabaletta Bio Inc. | CABA | Maintain | Buy (Buy) |
|
Details | ||
| 4/1/2026 | Apellis Pharmaceuticals | APLS | Downgrade | Neutral (Buy) |
40.23 (41.03) |
1.99% | Details | |
| 3/31/2026 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2026 | Rezolute | RZLT | Maintain | Buy (Buy) |
|
Details | ||
| 3/12/2026 | Minerva Neurosciences | NERV | Maintain | Neutral (N/A) |
|
Details | ||
| 3/4/2026 | Biohaven Pharma | BHVN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/4/2026 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2026 | Theravance Biopharma | TBPH | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2026 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2026 | Alkermes | ALKS | Maintain | Neutral (N/A) |
|
Details | ||
| 2/25/2026 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2026 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2026 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 1/30/2026 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 1/30/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2026 | Crinetics | CRNX | Maintain | Buy (Buy) |
|
Details | ||
| 1/6/2026 | argenx SE | ARGX | Maintain | Buy (Buy) |
|
Details | ||
| 1/5/2026 | Outlook Therapeutics Inc. | OTLK | Maintain | Neutral (N/A) |
|
Details | ||
| 1/2/2026 | Outlook Therapeutics Incs. | OTLK | Maintain | Neutral (N/A) |
|
Details | ||
| 12/30/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (Buy) |
|
Details | ||
| 12/26/2025 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Neutral (Neutral) |
|
Details | ||
| 12/15/2025 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2025 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2025 | Disc Medicine | IRON | Maintain | Buy (Buy) |
|
Details | ||
| 12/9/2025 | Rapport Therapeutics | RAPP | Maintain | Buy (N/A) |
|
Details | ||
| 12/5/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2025 | Biohaven Pharmaceutical Holding | BHVN | Downgrade | Neutral (Buy) |
8.83 (15.55) |
76.1% | Details | |
| 12/2/2025 | Dare Bioscience | DARE | Maintain | Buy (Buy) |
|
Details | ||
| 12/2/2025 | Evolus | EOLS | Maintain | Buy (Buy) |
|
Details | ||
| 11/20/2025 | Alkermes | ALKS | Maintain | Neutral (Neutral) |
|
Details | ||
| 11/17/2025 | Pacira Pharmaceuticals | PCRX | New Coverage | Buy (N/A) |
23.78 (25.48) |
7.15% | Details | |
| 11/11/2025 | Theravance Biopharma | TBPH | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2025 | Minerva Neurosciences | NERV | Maintain | Neutral (N/A) |
|
Details | ||
| 10/31/2025 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2025 | Cabaletta Bio Inc. | CABA | Maintain | Buy (Buy) |
|
Details | ||
| 10/23/2025 | Neumora Therapeutics | NMRA | Maintain | Buy (Buy) |
|
Details | ||
| 10/23/2025 | Alkermes | ALKS | Maintain | Neutral (Neutral) |
|
Details | ||
| 10/21/2025 | Viridian Therapeutic | VRDN | Maintain | Buy (Buy) |
|
Details | ||
| 10/21/2025 | Apellis Pharmaceuticals | APLS | Maintain | Buy (Buy) |
|
Details | ||
| 10/17/2025 | Disc Medicine | IRON | Maintain | Buy (Buy) |
|
Details | ||
| 9/30/2025 | Outlook Therapeutics Incs. | OTLK | Maintain | Neutral (Neutral) |
|
Details | ||
| 9/29/2025 | Apellis Pharmaceuticals | APLS | Maintain | Buy (Buy) |
|
Details | ||
| 9/26/2025 | Crinetics | CRNX | Maintain | Buy (Buy) |
|
Details | ||
| 9/18/2025 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2025 | Alkermes | ALKS | Maintain | Neutral (Neutral) |
|
Details | ||
| 9/9/2025 | Rapport Therapeutics | RAPP | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2025 | Rezolute | RZLT | Maintain | Buy (Buy) |
|
Details | ||
| 8/29/2025 | scPharmaceuticals | SCPH | Downgrade | Neutral (Buy) |
5.51 (5.67) |
2.9% | Details | |
| 8/29/2025 | Outlook Therapeutics Incs. | OTLK | Downgrade | Neutral (Buy) |
1.09 (1.57) |
44.04% | Details | |
| 8/14/2025 | Evotec | EVO | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2025 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | Cabaletta Bio Inc. | CABA | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2025 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2025 | Rapport Therapeutics | RAPP | New Coverage | Buy (N/A) |
14.43 (41.75) |
189.33% | Details | |
| 8/5/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2025 | Alkermes | ALKS | Maintain | Neutral (Neutral) |
|
Details | ||
| 7/21/2025 | Crinetics | CRNX | Maintain | Buy (Buy) |
|
Details | ||
| 7/18/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (Buy) |
|
Details | ||
| 7/15/2025 | Dare Bioscience | DARE | Maintain | Buy (Buy) |
|
Details | ||
| 7/14/2025 | Apellis Pharmaceuticals | APLS | Maintain | Buy (Buy) |
|
Details | ||
| 7/10/2025 | Neumora Therapeutics | NMRA | Maintain | Buy (Buy) |
|
Details | ||
| 7/3/2025 | Disc Medicine | IRON | Maintain | Buy (Buy) |
|
Details | ||
| 7/1/2025 | Protagonist Therapeutics | PTGX | Maintain | Buy (Buy) |
|
Details | ||
| 7/1/2025 | argenx SE | ARGX | Maintain | Buy (Buy) |
|
Details | ||
| 6/30/2025 | Xenon Pharmaceuticals | XENE | Maintain | Buy (Buy) |
|
Details | ||
| 6/27/2025 | Crinetics | CRNX | Maintain | Buy (Buy) |
|
Details | ||
| 6/18/2025 | Sage Therapeutics | SAGE | Maintain | Neutral (Neutral) |
|
Details | ||
| 6/18/2025 | Roivant Sciences | ROIV | Maintain | Buy (Buy) |
|
Details | ||
| 6/17/2025 | Disc Medicine | IRON | Maintain | Buy (Buy) |
|
Details | ||
| 6/12/2025 | Cabaletta Bio Inc. | CABA | Maintain | Buy (Buy) |
|
Details | ||
| 6/10/2025 | argenx SE | ARGX | Maintain | Buy (Buy) |
|
Details | ||
| 6/5/2025 | Dare Bioscience | DARE | Maintain | Buy (Buy) |
|
Details | ||
| 6/3/2025 | Protagonist Therapeutics | PTGX | Maintain | Buy (Buy) |
|
Details | ||
| 5/30/2025 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (Buy) |
|
Details | ||
| 5/30/2025 | Crinetics | CRNX | Maintain | Buy (Buy) |
|
Details | ||
| 5/30/2025 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2025 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2025 | Neumora Therapeutics | NMRA | Maintain | Buy (Buy) |
|
Details | ||
| 4/22/2025 | Roivant Sciences | ROIV | Maintain | Buy (Buy) |
|
Details | ||
| 4/21/2025 | Evotec | EVO | Maintain | Buy (Buy) |
|
Details | ||
| 4/11/2025 | Protagonist Therapeutics | PTGX | Maintain | Buy (Buy) |
|
Details | ||
| 4/11/2025 | argenx SE | ARGX | Maintain | Buy (Buy) |
|
Details | ||
| 4/10/2025 | Evolus | EOLS | Maintain | Buy (Buy) |
|
Details | ||
| 3/20/2025 | Immunovant | IMVT | Maintain | Buy (Buy) |
|
Details | ||
| 3/10/2025 | Neumora Therapeutics | NMRA | Maintain | Buy (Buy) |
|
Details | ||
| 3/10/2025 | Protagonist Therapeutics | PTGX | Maintain | Buy (Buy) |
|
Details | ||
| 3/7/2025 | scPharmaceuticals | SCPH | Maintain | Buy (Buy) |
|
Details | ||
| 3/5/2025 | Evolus | EOLS | Maintain | Buy (Buy) |
|
Details | ||
| 3/5/2025 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (Buy) |
|
Details | ||
| 3/4/2025 | Protagonist Therapeutics | PTGX | Maintain | Buy (Buy) |
|
Details | ||
| 3/4/2025 | Neumora Therapeutics | NMRA | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2025 | Theravance Biopharma | TBPH | Maintain | Buy (Buy) |
|
Details | ||
| 2/24/2025 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2025 | Outlook Therapeutics Incs. | OTLK | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2025 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 2/10/2025 | Immunovant | IMVT | Maintain | Buy (Buy) |
|
Details | ||
| 2/5/2025 | Rezolute | RZLT | Maintain | Buy (Buy) |
|
Details | ||
| 1/17/2025 | Cabaletta Bio Inc. | CABA | Maintain | Buy (Buy) |
|
Details | ||
| 1/14/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2025 | Neumora Therapeutics | NMRA | Maintain | Buy (Buy) |
|
Details | ||
| 12/17/2024 | Viridian Therapeutic | VRDN | Maintain | Buy (Buy) |
|
Details | ||
| 12/17/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (Buy) |
|
Details | ||
| 12/16/2024 | Neumora Therapeutics | NMRA | Maintain | Buy (Buy) |
|
Details | ||
| 12/12/2024 | Xenon Pharmaceuticals | XENE | Maintain | Buy (Buy) |
|
Details | ||
| 11/29/2024 | Outlook Therapeutics Incs. | OTLK | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2024 | Cabaletta Bio Inc. | CABA | Maintain | Buy (Buy) |
|
Details | ||
| 11/19/2024 | Protagonist Therapeutics | PTGX | Maintain | Buy (Buy) |
|
Details | ||
| 11/14/2024 | Trevena | TRVN | Downgrade | Neutral (Buy) |
2.50 (2.50) |
0% | Details | |
| 11/14/2024 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2024 | Xenon Pharmaceuticals | XENE | Maintain | Buy (Buy) |
|
Details | ||
| 11/13/2024 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2024 | Crinetics | CRNX | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2024 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2024 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2024 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 10/28/2024 | Disc Medicine | iRON | Maintain | Buy (Buy) |
|
Details | ||
| 10/28/2024 | Alkermes | ALKS | Maintain | Neutral (Neutral) |
|
Details | ||
| 10/25/2024 | Marinus Pharmaceuticals | MRNS | Downgrade | Neutral (Buy) |
0.30 (0.55) |
83.33% | Details | |
| 10/24/2024 | Dare Bioscience | DARE | Maintain | Buy (Buy) |
|
Details | ||
| 10/14/2024 | Alkermes | ALKS | Maintain | Neutral (Neutral) |
|
Details | ||
| 10/3/2024 | Evolus | EOLS | Maintain | Buy (Buy) |
|
Details | ||
| 10/1/2024 | AEON Biopharma, Inc | AEON | Maintain | Buy (Buy) |
|
Details | ||
| 10/1/2024 | Neumora Therapeutics | NMRA | New Coverage | Buy (N/A) |
13.21 (1.68) |
-87.28% | Details | |
| 10/1/2024 | Xenon Pharmaceuticals | XENE | New Coverage | Buy (N/A) |
39.37 (68.92) |
75.06% | Details | |
| 9/30/2024 | Immunovant | IMVT | Maintain | Buy (Buy) |
|
Details | ||
| 9/27/2024 | Rezolute | RZLT | Maintain | Buy (Buy) |
|
Details | ||
| 9/24/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (Buy) |
|
Details | ||
| 9/19/2024 | Roivant Sciences | ROIV | Maintain | Buy (Buy) |
|
Details | ||
| 9/17/2024 | Cabaletta Bio Inc. | CABA | Maintain | Buy (Buy) |
|
Details | ||
| 9/16/2024 | Theravance Biopharma | TBPH | Maintain | Buy (Buy) |
|
Details | ||
| 9/16/2024 | Disc Medicine | IRON | Maintain | Buy (Buy) |
|
Details | ||
| 9/12/2024 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2024 | Viridian Therapeutic | VRDN | Maintain | Buy (Buy) |
|
Details | ||
| 9/11/2024 | Roivant Sciences | ROIV | Maintain | Buy (Buy) |
|
Details | ||
| 9/10/2024 | Rezolute | RZLT | Maintain | Buy (Buy) |
|
Details | ||
| 9/10/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (Buy) |
|
Details | ||
| 9/10/2024 | Immunovant | IMVT | Maintain | Buy (Buy) |
|
Details | ||
| 9/4/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (Buy) |
|
Details | ||
| 8/19/2024 | scPharmaceuticals | SCPH | Maintain | Buy (Buy) |
|
Details | ||
| 8/19/2024 | Roivant Sciences | ROIV | Maintain | Buy (Buy) |
|
Details | ||
| 8/15/2024 | Evotec | EVO | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2024 | AEON Biopharma, Inc | AEON | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2024 | Revance Therapeutic | RVNC | Downgrade | Neutral (Buy) |
6.60 (3.65) |
-44.7% | Details | |
| 8/9/2024 | Cabaletta Bio Inc. | CABA | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2024 | Crinetics | CRNX | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2024 | Minerva Neurosciences | NERV | Maintain | Neutral (N/A) |
|
Details | ||
| 8/7/2024 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2024 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2024 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2024 | Alkermes | ALKS | Maintain | Neutral (N/A) |
|
Details | ||
| 7/18/2024 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2024 | Viridian Therapeutic | VRDN | Maintain | Buy (Buy) |
|
Details | ||
| 7/10/2024 | AEON Biopharma, Inc | AEON | Maintain | Buy (Buy) |
|
Details | ||
| 7/10/2024 | Disc Medicine | IRON | Maintain | Buy (Buy) |
|
Details | ||
| 7/3/2024 | Sage Therapeutics | SAGE | Maintain | Neutral (Neutral) |
|
Details | ||
| 6/26/2024 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2024 | argenx SE | ARGX | Maintain | Buy (Buy) |
|
Details | ||
| 6/17/2024 | Protagonist Therapeutics | PTGX | Maintain | Buy (Buy) |
|
Details | ||
| 6/14/2024 | argenx SE | ARGX | Maintain | Buy (Buy) |
|
Details | ||
| 5/17/2024 | Outlook Therapeutics Incs. | OTLK | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2024 | Trevena | TRVN | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2024 | AEON Biopharma, Inc | AEON | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2024 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2024 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2024 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2024 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2024 | Minerva Neurosciences | NERV | Maintain | Neutral (N/A) |
|
Details | ||
| 4/25/2024 | Evotec | EVO | Maintain | Buy (N/A) |
|
Details | ||
| 4/3/2024 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2024 | Outlook Therapeutics Incs. | OTLK | Maintain | Buy (N/A) |
|
Details | ||
| 3/22/2024 | Cabaletta Bio Inc. | CABA | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2024 | Crinetics | CRNX | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2024 | Crinetics | CRNX | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2024 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2024 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 2/16/2024 | Alkermes | ALKS | Maintain | Neutral (N/A) |
|
Details | ||
| 2/15/2024 | Outlook Therapeutics Incs. | OTLK | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2024 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 2/9/2024 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 1/17/2024 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2023 | Biohaven Pharmaceutical Holding | BHVN | New Coverage | Buy (N/A) |
38.02 (8.83) |
-76.78% | Details | |
| 12/21/2023 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2023 | Crinetics | CRNX | Maintain | Buy (N/A) |
|
Details | ||
| 12/7/2023 | Cerevel Therapeutics | CERE | Downgrade | Neutral (Buy) |
36.93 (44.96) |
21.74% | Details | |
| 12/1/2023 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 11/29/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2023 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2023 | Outlook Therapeutics Incs. | OTLK | Upgrade | Buy (Neutral) |
0.34 (1.57) |
361.76% | Details | |
| 10/24/2023 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 8/31/2023 | Outlook Therapeutics Incs. | OTLK | Downgrade | Neutral (Buy) |
0.27 (1.57) |
481.48% | Details | |
| 8/18/2023 | AEON Biopharma, Inc | AEON | New Coverage | Buy (N/A) |
4.34 (0.48) |
-88.94% | Details | |
| 8/14/2023 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2023 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2023 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2023 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 8/3/2023 | Cerevel Therapeutics | CERE | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2023 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2023 | Minerva Neurosciences | NERV | Maintain | Neutral (N/A) |
|
Details | ||
| 7/21/2023 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 7/18/2023 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2023 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 6/12/2023 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2023 | Disc Medicine | IRON | New Coverage | Buy (N/A) |
39.17 (76.59) |
95.53% | Details | |
| 5/24/2023 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2023 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2023 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2023 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2023 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2023 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2023 | Alkermes | ALKS | Maintain | Neutral (N/A) |
|
Details | ||
| 3/20/2023 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2023 | Cabaletta Bio Inc. | CABA | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2023 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2023 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2023 | Cerevel Therapeutics | CERE | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2023 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2023 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2023 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2023 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2023 | Outlook Therapeutics Incs. | OTLK | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2022 | Dare Bioscience | DARE | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2022 | scPharmaceuticals | SCPH | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2022 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2022 | Minerva Neurosciences | NERV | Downgrade | Neutral (Buy) |
3.26 (4.72) |
44.79% | Details | |
| 11/9/2022 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2022 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 11/9/2022 | Cerevel Therapeutics | CERE | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2022 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2022 | Horizon Therapeutics | HZNP | New Coverage | Neutral (N/A) |
62.32 (116.30) |
86.62% | Details | |
| 10/18/2022 | Minerva Neurosciences | NERV | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2022 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2022 | argenx SE | ARGX | Maintain | Neutral (N/A) |
|
Details | ||
| 7/19/2022 | Apellis Pharmaceuticals | APLS | New Coverage | Buy (N/A) |
44.76 (40.23) |
-10.12% | Details | |
| 6/7/2022 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2022 | Biohaven Pharmaceutical Holding | BHVN | Downgrade | Neutral (Buy) |
140.00 (15.55) |
-88.89% | Details | |
| 3/4/2022 | Minerva Neurosciences | NERV | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 12/23/2021 | Osmotica | OSMT | New Coverage | Buy (N/A) |
1.06 (1.11) |
4.72% | Details | |
| 12/16/2021 | Praxis Precision Medicines Inc. | PRAX | New Coverage | Buy (N/A) |
18.10 (324.99) |
1695.52% | Details | |
| 12/16/2021 | Cerevel Therapeutics | CERE | New Coverage | Buy (N/A) |
30.44 (44.96) |
47.7% | Details | |
| 11/9/2021 | Radius Health | RDUS | Maintain | Neutral (N/A) |
|
Details | ||
| 10/18/2021 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 10/13/2021 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 10/6/2021 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2021 | Outlook Therapeutics Incs. | OTLK | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2021 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2021 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 5/25/2021 | Rezolute | RZLT | New Coverage | Buy (N/A) |
6.45 (4.75) |
-26.36% | Details | |
| 5/10/2021 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2021 | argenx SE | ARGX | Upgrade | Buy (Neutral) |
263.70 (877.62) |
232.81% | Details | |
| 5/6/2021 | Chiasma | CHMA | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2021 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2021 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2021 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | Chiasma | CHMA | Maintain | Buy (N/A) |
|
Details | ||
| 2/22/2021 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2021 | GW Pharma | GWPH | Downgrade | Buy (Buy) |
211.37 (218.96) |
3.59% | Details | |
| 12/18/2020 | Dare Bioscience | DARE | New Coverage | Buy (N/A) |
1.13 (2.02) |
78.76% | Details | |
| 12/15/2020 | GW Pharma | GWPH | New Coverage | Buy (N/A) |
121.22 (218.96) |
80.63% | Details | |
| 11/6/2020 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 10/13/2020 | Cabaletta Bio Inc. | CABA | New Coverage | Buy (N/A) |
11.28 (2.98) |
-73.58% | Details | |
| 10/2/2020 | AMAG Pharmaceuticals | AMAG | Downgrade | Neutral (Buy) |
13.65 (13.75) |
0.73% | Details | |
| 8/27/2020 | Outlook Therapeutics Incs. | OTLK | Maintain | Buy (N/A) |
|
Details | ||
| 8/26/2020 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 8/25/2020 | Momenta Pharmaceuticals | MNTA | Downgrade | Neutral (Buy) |
52.15 (52.48) |
0.63% | Details | |
| 8/12/2020 | Chiasma | CHMA | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2020 | AMAG Pharmaceuticals | AMAG | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2020 | GW Pharma | GWPH | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2020 | Momenta Pharmaceuticals | MNTA | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2020 | Immunovant | IMVT | New Coverage | Buy (N/A) |
23.32 (39.71) |
70.28% | Details | |
| 7/29/2020 | argenx SE | ARGX | New Coverage | Neutral (N/A) |
253.23 (877.62) |
246.57% | Details | |
| 7/1/2020 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2020 | Chiasma | CHMA | Maintain | Buy (N/A) |
|
Details | ||
| 6/16/2020 | Momenta Pharmaceuticals | MNTA | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2020 | Minerva Neurosciences | NERV | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2020 | Minerva Neurosciences | NERV | Maintain | Buy (Buy) |
|
Details | ||
| 5/27/2020 | Outlook Therapeutics Incs. | OTLK | Maintain | Buy (Buy) |
|
Details | ||
| 5/18/2020 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2020 | scPharmaceuticals | SCPH | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2020 | AMAG Pharmaceuticals | AMAG | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2020 | AMAG Pharmaceuticals | AMAG | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2020 | GW Pharma | GWPH | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2020 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2020 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2020 | Theravance Biopharma | TBPH | Maintain | Buy (N/A) |
|
Details | ||
| 1/23/2020 | Dermira | DERM | Downgrade | Neutral (Buy) |
18.83 (7.47) |
-60.33% | Details | |
| 10/30/2019 | AMAG Pharmaceuticals | AMAG | Maintain | Buy (Buy) |
|
Details | ||
| 10/30/2019 | Sage Therapeutics | SAGE | New Coverage | Neutral (N/A) |
140.16 (8.68) |
-93.81% | Details | |
| 10/30/2019 | GW Pharma | GWPH | New Coverage | Buy (N/A) |
134.06 (218.96) |
63.33% | Details | |
| 10/15/2019 | scPharmaceuticals | SCPH | New Coverage | Buy (N/A) |
5.90 (5.67) |
-3.9% | Details | |
| 9/25/2019 | Momenta Pharmaceuticals | MNTA | New Coverage | Buy (N/A) |
13.10 (52.48) |
300.61% | Details | |
| 9/4/2019 | Trevena | TRVN | Maintain | Buy (Buy) |
|
Details | ||
| 7/18/2019 | Outlook Therapeutics Incs. | OTLK | New Coverage | Buy (N/A) |
2.02 (1.57) |
-22.28% | Details | |
| 7/8/2019 | Protagonist Therapeutics | PTGX | New Coverage | Buy (N/A) |
12.50 (131.42) |
951.36% | Details | |
| 5/31/2019 | Trevena | TRVN | New Coverage | Buy (N/A) |
1.19 (2.50) |
110.08% | Details | |
| 3/27/2019 | Dermira | DERM | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2019 | Radius Health | RDUS | New Coverage | Neutral (N/A) |
19.60 (30.00) |
53.06% | Details | |
| 2/14/2019 | Crinetics | CRNX | New Coverage | Buy (N/A) |
24.86 (42.03) |
69.07% | Details | |
| 2/14/2019 | Revance Therapeutic | RVNC | New Coverage | Buy (N/A) |
17.86 (3.65) |
-79.56% | Details | |
| 2/14/2019 | Evolus | EOLS | New Coverage | Buy (N/A) |
26.56 (6.61) |
-75.11% | Details | |
| 2/14/2019 | Chiasma | CHMA | New Coverage | Buy (N/A) |
3.53 (3.79) |
7.37% | Details |
